Presentation is loading. Please wait.

Presentation is loading. Please wait.

Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical.

Similar presentations


Presentation on theme: "Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical."— Presentation transcript:

1 Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes  Xiao-Dong Mo, Jun Kong, Ting Zhao, Lan-Ping Xu, Xiao-Hui Zhang, Dai-Hong Liu, Yu Wang, Huan Chen, Chen-Hua Yan, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang  Biology of Blood and Marrow Transplantation  Volume 20, Issue 12, Pages (December 2014) DOI: /j.bbmt Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Cumulative incidence of EMR for AML and ALL patients.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Kaplan-Meier estimates of overall survival: P = .523 (isolated EMR versus EMR+BMR), P = .169 (isolated EMR versus isolated BMR), P = .355 (EMR+BMR versus isolated BMR); P = .001 (isolated EMR versus non-EMR/BMR), P < .001 (isolated BMR versus non-EMR/BMR), and P < .001 (EMR+BMR versus non-EMR/BMR). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical."

Similar presentations


Ads by Google